Correction to: “Effects of Low-dose Methotrexate With Methimazole in Patients With Graves’ Disease: Results of a Randomized Clinical Trial” - Summary - MDSpire

Correction to: “Effects of Low-dose Methotrexate With Methimazole in Patients With Graves’ Disease: Results of a Randomized Clinical Trial”

  • October 16, 2024

  • 0 min

Share

Objective:

To correct an error in the abstract of the original study regarding the dosage of Methotrexate (MTX).

Key Findings:
  • The original dosage of Methotrexate was incorrectly stated as daily instead of weekly.
Interpretation:

The correction clarifies the treatment regimen for patients involved in the study.

Limitations:
Conclusion:

The article has been corrected online to reflect the accurate dosage of Methotrexate.

Original Source(s)

Correction to: “Effects of Low-dose Methotrexate With Methimazole in Patients With Graves’ Disease: Results of a Randomized Clinical Trial”

  • October 16, 2024

Related Content

Subclinical ocular alterations in Graves' disease: The FUMO score, a new tool to predict Graves' orbitopathy progression

How AI Is Shaping Thyroid Disease Care

A new review finds AI is transforming thyroid disease care across imaging, pathology, and follow-up, but gaps in generalizability, transparency, and clinical integration persist.

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.